98
Participants
Start Date
September 1, 2017
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2018
In-Person Perinatal OUD Treatment
Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine as part of standard of care.
Perinatal OUD Treatment via Telemedicine
Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine as part of standard of care..
The Medical University of South Carolina, Charleston
Medical University of South Carolina
OTHER